Home › Insys CEO Babich resigns, drugmaker tops 3Q expectations
 

Keywords :   


Insys CEO Babich resigns, drugmaker tops 3Q expectations

2015-11-05 19:25:14| Biotech - Topix.net

Michael L. Babich has resigned as president and CEO of Insys Therapeutics, a specialty drugmaker under investigation over sales of its powerful painkiller Subsys. Shares of the Chandler, Arizona, company jumped almost 10 percent Thursday morning as the company also announced third-quarter earnings that trumped analyst expectations and said it was buying back some stock.

Tags: ceo expectations tops resigns

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
03.07Hurricane Beryl Public Advisory Number 17A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07How Microsoft and Nvidia bet correctly to leapfrog Apple
03.07Acreage and stocks estimates push corn prices lower
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
More »